Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy

Akira Goto, Yasutaka Sukawa, Hisayoshi Igarashi, Kei Onodera, Yuka Aoki, Kazuya Suzuki, Kazuhiko Yonezawa, Atsushi Yawata, Toshihisa Kobayashi, Hiroyuki Kaneto, Haruo Shimizu, Hideki Wakasugi, Yasutaka Matsunaga, Miki Itoh, Hiroyuki Okuda, Yoshiaki Arimura, Yasuhisa Shinomura

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Irinotecan as the key chemotherapeutic agent in second-line treatment of metastatic gastric cancer after failure of first-line S-1 or S-1/CDDP therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences